Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Lifecare AS ( (DE:LFC0) ) has shared an announcement.
Lifecare ASA has allocated subscription rights to existing shareholders as part of a partially underwritten rights issue, granting 10.49 subscription rights per share held (rounded down), with each right allowing subscription for one new share at NOK 0.50. Primary insiders and their closely associated companies, including board members and senior executives such as CEO Joacim Holter and CSO Andreas Pfützner, have received large allocations through this automatic, free-of-charge process, though their underlying shareholdings remain unchanged; the transaction is intended to raise capital while maintaining transparency and regulatory compliance under Norwegian securities law.
More about Lifecare AS
Lifecare ASA is a medical sensor company developing technology for sensing and monitoring various body analytes, with a particular focus on bringing next-generation continuous glucose monitoring systems to market. Its proprietary sensor technology, based on osmotic pressure as the sensing principle, is designed for identifying and monitoring a wide range of analytes and molecules in humans and pets.
Average Trading Volume: 432,596
Current Market Cap: NOK219M
See more insights into LFC0 stock on TipRanks’ Stock Analysis page.